Over the past few years, Abbott Laboratories' (NYSE: ABT) business has been a bit of a roller coaster. The pandemic disrupted its medical device business, but it was later able to smooth out those ...

Abbott paved the way for the provision back in 2018 when it received a private letter ruling from the Internal Revenue Service allowing it to set up its own plan for entering employees into 401(k ...

Abbott Laboratories (ABT 0.51%) is a leading healthcare company with a global presence. It has a diverse business with four key segments: established pharmaceuticals, diagnostics, nutrition, and ...

Over the past few years, Abbott Laboratories' (ABT 0.16%) business has been a bit of a roller coaster. The pandemic disrupted its medical device business, but it was later able to smooth out those ...

Abbott Laboratories announced a plan to invest $500 million to expand its U.S. manufacturing footprint.. The medical device maker will upgrade facilities in both Illinois and Texas to expand its ...

Abbott Laboratories (NYSE:ABT) engages in the discovery, development, manufacturing, and sale of healthcare products. On July 29, 2024, Abbott Laboratories (NYSE:ABT) stock closed at $104.77 per ...

Abbott Labs recently added a new product to this business that could help improve its performance. Let's review the details and find out what it all means for investors. The leader in continuous ...